Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Long Term Monitoring of Safety in Subjects Treated With Duloxetine for Stress Urinary Incontinence

The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.

Inclusion Criteria:

• Female out patients
• Are ambulatory and are able to use a toilet independently and without difficulty.

Exclusion Criteria:

• Use of monoamine oxidase inhibitors (MAOIs)